Influence of Untreated Sleep-Disordered Breathing on the Long-Term Prognosis of Patients With Cardiovascular Disease

American Journal of Cardiology

Volumn 103, Issue 5, 2009, Pages 730-734

  Takama, Noriaki ^a,b   Kurabayashi, Masahiko ^b  

^a GUNMA UNIVERSITY   (Japan)

^b Public Tomioka General Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CENTRAL SLEEP APNEA SYNDROME; DISEASE ASSOCIATION; FATALITY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SLEEP APNEA SYNDROME; SLEEP DISORDERED BREATHING; SURVIVAL;

AGED; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; PROGNOSIS; SLEEP APNEA SYNDROMES; SURVIVAL RATE;

EID: 60249099568     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.10.035     Document Type: Article

References (29)

1. Javaheri S., Parker T.J., Liming J.D., Corbett W.S., Nishiyama H., Wexler L., and Roselle G.A. Sleep apnea in 81 ambulatory male patients with stable heart failure: types and their prevalences, consequences, and presentations. Circulation 97 (1998) 2154-2159
2. Peker Y., Hedner J., Kraiczi H., and Loth S. Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 162 (2000) 81-86
3. Takama N., and Kurabayashi M. Possibility of close relationship between sleep disordered breathing and acute coronary syndrome. J Cardiology 49 (2007) 171-178
4. Lanfranchi P.A., Braghiroli A., Bosimini E., Mazzuero G., Colombo R., Donner C.F., and Giannuzzi P. Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. Circulation 99 (1999) 1435-1440
5. Roebuck T., Solin P., Kaye D.M., Bergin P., Bailey M., and Naughton M.T. Increased long-term mortality in heart failure due to sleep apnoea is not yet proven. Eur Respir J 23 (2004) 735-740
6. Yumino D., Tsurumi Y., Takagi A., Suzuki K., and Kasanuki H. Impact of obstructive sleep apnea on clinical and angiographic outcomes following percutaneous coronary intervention in patients with acute coronary syndrome. Am J Cardiol 99 (2007) 26-30
7. Hanly P.J., and Zuberi-Khokhar N.S. Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure. Am J Respir Crit Care Med 153 (1996) 272-276
8. Sin D.D., Logan A.G., Fitzgerald F.S., Liu P.P., and Bradley T.D. Effects of continuous positive airway pressure on cardiovascular outcomes in heart failure patients with and without Cheyne-Stokes respiration. Circulation 102 (2000) 61-66
9. Cassar A., Morgenthaler T.I., Lennon R.J., Rihal C.S., and Lerman A. Treatment of obstructive sleep apnea is associated with decreased cardiac death after percutaneous coronary intervention. J Am Coll Cardiol 50 (2007) 1310-1314
10. Buchner N.J., Sanner B.M., Borgel J., and Rump L.C. Continuous positive airway pressure treatment of mild to moderate obstructive sleep apnea reduces cardiovascular risk. Am J Respir Crit Care Med 176 (2007) 1274-1280
11. Philippe C., Stoïca-Herman M., Drouot X., Raffestin B., Escourrou P., Hittinger L., Michel P.L., Rouault S., and d'Ortho M.P. Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period. Heart 92 (2006) 337-342
12. Arzt M., Floras J.S., Logan A.G., Kimoff R.J., Series F., Morrison D., Ferguson K., Belenkie I., Pfeifer M., Fleetham J., et al., CANPAP Investigators. Suppression of central sleep apnea by continuous positive airway pressure and transplant-free survival in heart failure: a post hoc analysis of the Canadian Continuous Positive Airway Pressure for Patients with Central Sleep Apnea and Heart Failure Trial (CANPAP). Circulation 115 (2007) 3173-3180
13. Wang H., Parker J.D., Newton G.E., Floras J.S., Mak S., Chiu K.L., Ruttanaumpawan P., Tomlinson G., and Bradley T.D. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol 49 (2007) 1625-1631
14. Mooe T., Franklin K.A., Holmström K., Rabben T., and Wiklund U. Sleep-disordered breathing and coronary artery disease: long term prognosis. Am J Respir Crit Care Med 164 (2001) 1910-1913
15. Burgess K.R. Central sleep apnea and heart failure (Part I). Respirology 2 (1997) 243-253
16. Sin D.D., Fitzgerald F., Parker J.D., Newton G., Floras J.S., and Bradley T.D. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 160 (1999) 1101-1106
17. Shahar E., Whitney C.W., Redline S., Lee E.T., Newman A.B., Javier Nieto F., O'Connor G.T., Boland L.L., Schwartz J.E., and Samet J.M. Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163 (2001) 19-25
18. Mooe T., Rabben T., Wiklund U., Franklin K.A., and Eriksson P. Sleep-disordered breathing in women: occurrence and association with coronary artery disease. Am J Med 101 (1996) 251-256
19. Moruzzi P., Sarzi-Braga S., Rossi M., and Contini M. Sleep apnoea in ischaemic heart disease: differences between acute and chronic coronary syndromes. Heart 82 (1999) 343-347
20. Mooe T., Franklin K.A., Wiklund U., Rabben T., and Holmstrom K. Sleep-disordered breathing and myocardial ischemia in patients with coronary artery disease. Chest 117 (2000) 1597-1602
21. Schafer H., Koehler U., Ploch T., and Peter J.H. Sleep-related myocardial ischemia and sleep structure in patients with obstructive sleep apnea and coronary heart disease. Chest 111 (1997) 387-393
22. Vgontzas A.N., Bixler E.O., and Chrousos G.P. Sleep apnea is a manifestation of the metabolic syndrome. Sleep Med Rev 9 (2005) 211-224
23. Milleron O., Pilliere R., Foucher A., de Roquefeuil F., Aegerter P., Jondeau G., Raffestin B.G., and Dubourg O. Benefits of obstructive sleep apnea treatment in coronary artery disease: a long-term follow-up study. Eur Heart J 25 (2004) 728-734
24. Martinez-Garcia M.A., Galiano-Blancart R., Roman-Sanchez P., Soler-Cataluna J.J., Cabero-Salt L., and Salcedo-Maiques E. Continuous positive airway pressure treatment in sleep apnea prevents new vascular events after ischemic stroke. Chest 128 (2005) 2123-2129
25. Campos-Rodriguez F., Peña-Griñan N., Reyes-Nuñez N., De la Cruz-Moron I., Perez-Ronchel J., De la Vega-Gallardo F., and Fernandez-Palacin A. Mortality in obstructive sleep apnea-hypopnea patients treated with positive airway pressure. Chest 128 (2005) 624-633
26. Marin J.M., Carrizo S.J., Vicente E., and Agusti A.G. Long-term cardiovascular outcomes in men with obstructive sleep apnea-hypopnea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365 (2005) 1046-1053
27. Calleja J.M., Esnaola S., Rubio R., and Durán J. Comparison of a cardiorespiratory device versus polysomnography for diagnosis of sleep apnoea. Eur Respir J 20 (2002) 1505-1510
28. Yan A.T., Bradley T.D., and Liu P.P. The role of continuous positive airway pressure in the treatment of congestive heart failure. Chest 120 (2001) 1675-1685
29. Kasai T., Narui K., Dohi T., Yanagisawa N., Ishiwata S., Ohno M., Yamaguchi T., and Momomura S. Prognosis of patients with heart failure and obstructive sleep apnea treated with continuous positive airway pressure. Chest 133 (2008) 690-696